Viewing Study NCT00801060

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-07-02 @ 12:17 AM
Study NCT ID: NCT00801060
Status: TERMINATED
Last Update Posted: 2015-10-02
First Post: 2008-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Sponsor: Biogen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD23 View
None Fludara View
None Cyclophosphamide View
None Antibody View
None Fludarabine View
None CLL View
None Rituximab View
None Mabthera View
None Biogen Idec View
None Lumiliximab View
None Rituxan View
None Cytoxan View
None Chronic Lymphocytic Leukemia View